Literature DB >> 1281569

HLA matching effect in liver transplantation.

A Yagihashi1, M Kobayashi, K Noguchi, A Konno, Y Yoshida, K Terasawa, T E Starzl, Y Iwaki.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1281569      PMCID： PMC2967351     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study.

Authors:  G Opelz; J Mytilineos; S Scherer; H Dunckley; J Trejaut; J Chapman; D Middleton; D Savage; O Fischer; J D Bignon
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

2.  Liver transplantation: an unfinished product.

Authors:  T E Starzl; S Todo; A G Tzakis; R D Gordon; L Makowka; A Stieber; L Podesta; K Yanaga; W Concepcion; S Iwatsuki
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

4.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

5.  Extended preservation of human liver grafts with UW solution.

Authors:  S Todo; J Nery; K Yanaga; L Podesta; R D Gordon; T E Starzl
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272
  5 in total
  7 in total

Review 1.  Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis.

Authors:  Xiang Lan; Ming-Man Zhang; Cong-Lun Pu; Chun-Bao Guo; Quan Kang; Ying-Chun Li; Xiao-Ke Dai; Yu-Hua Deng; Qiang Xiong; Zhi-Mei Ren
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 2.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

3.  The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation.

Authors:  R Mañez; R Mateo; J Tabasco; S Kusne; T E Starzl; R J Duquesnoy
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

Review 4.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 5.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Donor-recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplant.

Authors:  Christopher Bricogne; Neil Halliday; Raymond Fernando; Emmanuel A Tsochatzis; Brian R Davidson; Mark Harber; Rachel H Westbrook
Journal:  Liver Transpl       Date:  2022-05-04       Impact factor: 6.112

7.  Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.

Authors:  F Boix; I Legaz; A Minhas; R Alfaro; V Jiménez-Coll; A Mrowiec; H Martínez-Banaclocha; J A Galián; C Botella; M R Moya-Quiles; F Sanchez-Bueno; R Robles; J de la Peña-Moral; P Ramirez; J A Pons; A Minguela; M Muro
Journal:  Clin Exp Immunol       Date:  2020-10-29       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.